课题基金 / 基金详情

CATARACT RELATED MODIFICATIONS OF LENS CRYSTALLINS

CATARACT RELATED MODIFICATIONS OF LENS CRYSTALLINS
与白内障相关的晶状体晶体蛋白的改变
批准号:
6518426
负责人:
DAVID L. SMITH
金额:
$31.01万
依托单位国家:
美国
项目类别:
财政年份:
1989
资助国家:
美国
项目状态:
已结题
起止时间:
1989-04-01 至 2004-03-31

项目摘要

项目成果

DAVID L. SMITH的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
A large body of evidence supports the hypothesis that lens opacity is due to crystallin aggregation. To determine possible causes of this aggregation, our current research program has been directed towards identifying all of the major covalent modifications occurring in vivo to human lens crystallins with emphasis on distinguishing between clear and cataractous lenses. More broadly, the goal of this research has been to elucidate the chemistry that initiates or propagates cataract, which includes the chemistry of aging. Our use of mass spectrometry has led to major advances in identifying these covalent modifications. For example, it has been possible to unequivocally distinguish among a variety of age-related modifications that cause the proteins to be more acidic, such as phosphorylation, deamidation and lysine modification, and to readily identify multiple degradation products. All the major sites of modification in all the major gene products of the water-soluble portion of the lens have been identified. The renewal application includes four Specific Aims. Aim 1 will extend our present studies to include identification of covalent modifications to crystallins present in the water-insoluble fractions of clear and cataractous human lenses. Effective pursuit of this goal includes collaboration with Prof. Larry David (Oregon Health Sciences University). Dr. David requests a subcontract for this collaboration in lieu of direct competition with renewal of his R01 grant. In Aims 2-4, we shall explore linkages between known in vivo modifications of human lens crystallins and their propensity to aggregate. Specific Aim 2 will determine the effect of modifications of beta- and gamma- crystallins on their solubility. In Aim 3, new and highly detailed structural information will be obtained about the mechanisms through which alpha-crystallins solubilize gamma- crystallins. Aim 4 will address the effects of specific modifications to alpha-crystallins that inhibit their ability to perform this chaperone function. New analytical methods based on amide hydrogen exchange and lysine reactivity will be used to accomplish Aims 3 and 4.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
STRUCTURE ELUCIDATION OF PROTEINS BY MASS SPECTROMETRY
  • 批准号:
    6208627
  • 项目类别:
  • 资助金额:
    $3.23万
  • 财政年份:
    2001
  • 负责人:
    DAVID L. SMITH
  • 依托单位:
CATARACT RELATED MODIFICATIONS OF LENS CRYSTALLINS
  • 批准号:
    2859232
  • 项目类别:
  • 资助金额:
    $30.88万
  • 财政年份:
    1989
  • 负责人:
    DAVID L. SMITH
  • 依托单位:
CATARACT RELATED MODIFICATIONS OF LENS CRYSTALLINS
  • 批准号:
    3264652
  • 项目类别:
  • 资助金额:
    $5.7万
  • 财政年份:
    1989
  • 负责人:
    DAVID L. SMITH
  • 依托单位:
CATARACT RELATED MODIFICATIONS OF HUMAN LENS CRYSTALLINS
  • 批准号:
    3264647
  • 项目类别:
  • 资助金额:
    $13.73万
  • 财政年份:
    1989
  • 负责人:
    DAVID L. SMITH
  • 依托单位:
海外基金